Dapsone Oral Tablet 100Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Dapsone: Oral tablet (100mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_2027.JPG
Dapsone 100mg Tab
Jacobus Pharmaceutical Co
Pill Identification: 100 101  |  Jacobus

What is this Medicine?

DAPSONE (DAP sone) is an antiinfective. It is used to treat a skin problem called Dermatitis herpetiformis. This medicine is also used to treat leprosy.

CVS Pharmacy Patient Statistics for Dapsone: Oral tablet(100mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Dapsone 100mg Tablet

NDC: 499380101
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Leprosy (Hansen's Disease), Dermatitis Herpetiformis

Sometimes used for but not FDA approved for the following conditions:
Toxoplasmosis Prophylaxis, Pneumocystis Pneumonia (PCP) Prophylaxis, Pneumocystis Pneumonia (PCP), Subcorneal Pustular Dermatosis, Pyoderma Gangrenosum, Polychondritis, Granuloma Annulare, Actinomycotic Mycetoma, Idiopathic Thrombocytopenic Purpura (ITP)

Storage Information
Protect from light
Store at controlled room temperature (between 68 and 77 degrees F)
Dapsone 100mg Tablet
Drug Image file DrugItem_2027.JPG
Jacobus Pharmaceutical Co
Pill Identification: 100 101  |  Jacobus
Shape: round
Color: white

Reported Side Effects for Dapsone 100mg Tablet

Nerve Pain Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Blistery Rash Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Rash Of Red Skin Bumps Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Lyell'S Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Weakness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Exfoliative Dermatitis Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Erythema Multiforme Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Headache Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Nose Bleed Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
Depression Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Fever Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Anemia Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Feeling Sick Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Hemolysis Incidence:
>10.0%*
Severity: MODERATE
Onset: EARLY
Inflamed Iris (Eye) Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
High Methemoglobin Incidence:
>10.0%*
Severity: SEVERE
Onset: EARLY
Inflamed Blood Vessels Incidence:
>10.0%*
Severity: SEVERE
Onset: DELAYED
Inflamed Nerve Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Skin Redness Incidence:
13.0%*
Severity: MODERATE
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Dapsone

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.